V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10445196 | 10033805 | 1.7 | 92 | Palliative (P) | 2017-04-25 | 2017-04-25 | Rituximab | 02 | N | RITUXIMAB | 100476123 |
| 10445215 | 10033806 | 1.74 | 56.1 | Palliative (P) | 2017-01-04 | 2017-01-13 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100043836 |
| 10445248 | 10033807 | null | 68.1 | Palliative (P) | 2018-09-03 | 2018-09-09 | Rituximab | 02 | N | RITUXIMAB | 100912878 |
| 10445253 | 10033808 | 1.85 | 66 | Curative (C) | 2021-09-04 | 2021-09-12 | IBRUTINIB | 02 | N | IBRUTINIB | 101350712 |
| 10445299 | 10033809 | 1.64 | 76.2 | Curative (C) | 2016-07-23 | 2016-07-29 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100975041 |
| 10445311 | 10033810 | 1.76 | 76.3 | 03 | 2018-05-26 | 2018-06-06 | Capecitabine | 02 | N | CAPECITABINE | 101357668 |
| 10445348 | 10033811 | 1.47 | 78 | Adjuvant (A) | 2018-06-27 | 2018-06-27 | IBRUTINIB | 02 | N | IBRUTINIB | 101721374 |
| 10445351 | 10033812 | 1.64 | 70 | null | 2019-10-10 | 2019-10-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100065595 |
| 10445358 | 10033813 | 1.76 | 74 | Palliative (P) | 2017-05-04 | 2017-05-14 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101246856 |
| 10445373 | 10033814 | 1.69 | 73 | Palliative (P) | 2018-04-04 | 2018-04-04 | IBRUTINIB | 02 | N | IBRUTINIB | 101651151 |
| 10445381 | 10033815 | 1.78 | 94 | Palliative (P) | 2018-07-10 | 2018-07-10 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101861569 |
| 10445384 | 10033816 | 1.7 | 75 | null | 2017-09-17 | 2017-10-16 | Capecitabine | 02 | null | CAPECITABINE | 100621520 |
| 10445388 | 10033817 | null | 53.7 | Adjuvant (A) | 2017-01-07 | 2017-01-25 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100610083 |
| 10445402 | 10033818 | 1.88 | 69.1 | Disease modification (D) | 2017-09-07 | 2017-09-16 | Rituximab | 02 | N | RITUXIMAB | 101319618 |
| 10445403 | 10033819 | 1.54 | 99 | Curative (C) | 2018-10-17 | 2018-10-18 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 100834788 |
| 10445423 | 10033820 | 1.73 | 88.2 | Disease modification (D) | 2019-11-12 | 2019-11-20 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100320926 |
| 10445425 | 10033821 | 1.75 | 118 | Adjuvant (A) | 2018-06-11 | 2018-07-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100554650 |
| 10445437 | 10033822 | 1.6 | 89 | null | 2019-05-29 | 2019-06-17 | Capecitabine 5days + RT | 02 | null | CAPECITABINE | 100519016 |
| 10445438 | 10033823 | 1.55 | 0 | null | 2022-01-07 | 2022-01-28 | Capecitabine | 02 | null | CAPECITABINE | 101310147 |
| 10445447 | 10033824 | 1.89 | 81.5 | Neo-adjuvant (N) | 2018-12-22 | 2019-01-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101225135 |
| 10445492 | 10033825 | 1.61 | 78.4 | Curative (C) | 2020-01-23 | 2020-02-02 | IBRUTINIB | 02 | N | IBRUTINIB | 101777020 |
| 10445500 | 10033826 | 1.58 | 101.9 | Adjuvant (A) | 2016-06-28 | 2016-07-15 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE | 101768964 |
| 10445506 | 10033827 | 1.75 | 74.8 | Palliative (P) | 2017-11-10 | 2017-11-10 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101443283 |
| 10445539 | 10033828 | 1.62 | 60 | null | 2021-12-04 | 2021-12-04 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100082371 |
| 10445550 | 10033829 | 1.78 | 49.1 | null | 2019-09-08 | 2019-09-14 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101007574 |
| 10445552 | 10033830 | 1.8 | 56.6 | 03 | 2018-06-26 | 2018-07-06 | PEMBROLIZUMAB | 2 | N | PEMBROLIZUMAB | 101209405 |
| 10445591 | 10033831 | 1.8 | 61.8 | null | 2018-11-27 | 2018-12-07 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101278730 |
| 10445603 | 10033832 | 1.65 | 89.66 | Curative (C) | 2015-11-26 | 2016-10-30 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100349803 |
| 10445609 | 10033833 | 1.8 | 55.2 | Palliative (P) | 2016-08-17 | 2016-08-25 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 100192069 |
| 10445635 | 10033834 | 1.74 | 80 | null | 2017-09-25 | 2017-10-20 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101460796 |
| 10445638 | 10033835 | 1.66 | 88.5 | Palliative (P) | 2019-10-31 | 2019-10-31 | IBRUTINIB | 02 | N | IBRUTINIB | 100423566 |
| 10445641 | 10033836 | 1.82 | 58 | Palliative (P) | 2018-02-17 | 2018-03-03 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100264582 |
| 10445655 | 10033837 | 1.6 | 59.4 | 03 | null | 2016-07-16 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101118739 |
| 10445673 | 10033838 | 1.69 | 111.9 | Adjuvant (A) | 2021-09-09 | 2021-09-20 | Docetaxel | 02 | N | DOCETAXEL | 100242747 |
| 10445675 | 10033839 | 1.64 | 89.9 | Neo-adjuvant (N) | 2020-10-06 | 2020-10-20 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100590987 |
| 10445682 | 10033840 | 1.75 | 45.4 | Disease modification (D) | 2018-10-24 | 2018-11-02 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100999906 |
| 10445687 | 10033841 | 1.67 | 96.4 | Adjuvant (A) | 2018-12-14 | 2018-12-23 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101864706 |
| 10445688 | 10033842 | null | null | Palliative (P) | 2021-07-05 | 2021-07-18 | Capecitabine + Oxaliplatin 21day | Y | N | IBRUTINIB | 101848199 |
| 10445703 | 10033843 | 1.81 | 87.2 | 03 | 2018-12-09 | 2019-03-12 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101853250 |
| 10445721 | 10033844 | 1.66 | 62.1 | null | 2021-09-07 | 2021-09-22 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 101753504 |
| 10445722 | 10033845 | 1.63 | 81 | Adjuvant (A) | 2018-03-19 | 2018-04-30 | IBRUTINIB | 02 | N | IBRUTINIB | 101405268 |
| 10445735 | 10033846 | 1.62 | null | Disease modification (D) | 2018-12-19 | 2019-01-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101325450 |
| 10445740 | 10033847 | 1.52 | 49.1 | null | 2019-06-19 | 2019-06-29 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101382950 |
| 10445768 | 10033849 | 1.83 | 86.6 | 03 | 2018-11-20 | 2018-11-30 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100603151 |
| 10445771 | 10033850 | null | null | null | 2016-11-24 | 2016-12-08 | Capecitabine + Oxaliplatin 21day | 02 | null | RITUXIMAB | 100388423 |
| 10445774 | 10033851 | 1.58 | 83 | Palliative (P) | 2017-02-19 | 2017-02-20 | CAPECITABINE + OXALIPLATIN | N | N | IBRUTINIB | 100429060 |
| 10445775 | 10033852 | 1.78 | 96.8 | Curative (C) | 2019-11-15 | 2019-12-05 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 101759605 |
| 10445800 | 10033853 | 1.74 | 62.6 | 03 | 2018-04-29 | 2018-05-21 | Capecitabine | 02 | N | CAPECITABINE | 101337529 |
| 10445813 | 10033854 | null | 95.4 | Palliative (P) | 2017-11-09 | 2017-11-16 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100787128 |
| 10445826 | 10033855 | 1.61 | 81.8 | Neo-adjuvant (N) | 2019-08-04 | 2019-08-12 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 100177806 |